Formulator's Corner #20: Menopause Brain Fog Formula - Memo-Q Meets Functional Chocolate

In today's installment of our Formulator's Corner Series, we create a hypothetical functional chocolate supplement specifically designed for women navigating menopause-related cognitive challenges. Will a forward-thinking brand bring this science-backed indulgence to market?

Formulator's Corner #20: Menopause Brain Fog Formula - Memo-Q Meets Functional Chocolate

Formulator's Corner #20 examines a hypothetical functional chocolate featuring Memo-Q silk protein designed to support cognitive function and brain fog during menopause. Research from ten clinical trials backs this ingredient's potential memory benefits.

The Silent Struggle: When Brain Fog Clouds the Best Years

Menopause is a universal transition, yet its cognitive effects remain underrecognized and undertreated. Nearly 75% of women report disruptive symptoms such as hot flashes and sleep disturbances, while brain fog (forgetfulness, mental fatigue, and difficulty concentrating) affects up to 60% during this stage.[1] Millions are left searching for solutions beyond the familiar refrain of "it's just hormones".

The convergence of breakthrough dietary supplement ingredients and evolving consumer preferences creates an unprecedented opportunity. Women aged 45+ increasingly reject the notion that cognitive decline is an inevitable part of aging. They want targeted, science-backed solutions that acknowledge the complex interplay between hormones, neurotransmitters, and nutrition.

Memo-Q For Brain Fog: A Novel Silk Protein Peptide

Enter Memo-Q, Freemen Nutra's revolutionary silk protein fibroin hydrolysate that's rewriting the playbook on cognitive enhancement. When combined with strategic supporting ingredients in an indulgent functional chocolate format, we have the blueprint for a supplement that doesn't just mask symptoms -- it addresses the root causes of menopausal brain fog.

Why Functional Chocolate? The Perfect Delivery System

Memo-Q Logo

Chocolate isn't just about palatability, it's a strategic choice. The format offers natural mood-enhancing compounds (theobromine, anandamide), provides a comforting daily ritual during a challenging life transition, and helps mask the taste of functional ingredients without synthetic flavoring. Most importantly, it transforms supplementation from a chore into a moment of self-care.

The proposed format: 4 chocolate squares daily delivering the full clinical dose of each ingredient, with some supporting vitamins and minerals along the way. Women can enjoy all four squares at once or split them throughout the day for sustained cognitive support.

Before we dig in, sign up for our Freemen Nutra news alerts, as they have a lot more interesting ingredients coming:

Subscribe to PricePlow's Newsletter and Alerts on These Topics

Topic Blog Posts YouTube Videos Instagram Posts
Freemen Nutra
Memo-Q

The Core Formula: Science Meets Indulgence

In four chocolate squares, you'd get the following:

Formulator's Corner #20 Memo-Q Menopause Chocolate Formula

  • Memo-Q Silk Protein Fibroin Hydrolysate (400mg)

    At the heart of our formula lies 400mg of Memo-Q, delivering the upper range of clinically-studied doses for maximum cognitive impact. Why the maximum dose? Beyond the fact that this is our dream formula, the research shows dose-dependent benefits, with 200-600mg daily providing the greatest improvements in memory and focus.

    Unprecedented Clinical Foundation

    Memo-Q stands apart with 10 human clinical trials spanning two decades and every age group from children to seniors in their 90s. This research breadth is virtually unmatched in the supplement industry, demonstrating consistent cognitive benefits across diverse populations.[2] While our formula targets menopausal women, the ingredient's safety profile allows flexibility -- even a single chocolate square (150mg) can benefit younger family members without concern.

    The Acetylcholine Advantage

    Memo-Q's primary mechanism involves protecting and enhancing acetylcholine availability through multiple complementary pathways. During menopause, declining estrogen already compromises cholinergic function, making acetylcholine preservation crucial for maintaining memory and attention.

    Research demonstrates that Memo-Q helps restore acetylcholine levels that have been depleted by neurotoxic challenges. In preclinical studies, when beta-amyloid reduced acetylcholine to just 45% of normal levels, treatment with silk protein hydrolysate recovered concentrations to 78-80% of control levels.[2] This protective effect occurs without supplying additional choline, suggesting the ingredient works by preserving existing neurotransmitter stores rather than simply providing building blocks.

    Additionally, studies show that fibroin enzymatic hydrolysate can suppress acetylcholinesterase (AChE) levels in damaged brain tissue, helping prevent the breakdown of this critical memory neurotransmitter.[3] This dual approach of protecting existing acetylcholine while reducing its enzymatic breakdown creates a powerful foundation for cognitive enhancement.

    By preserving existing acetylcholine while our other ingredients support new synthesis, Memo-Q creates a dual-action approach that directly addresses the memory lapses and attention deficits that characterize menopausal brain fog. This protection of the cholinergic system provides sustained cognitive support throughout the challenging hormonal transition of menopause.

    Memo-Q: The Silk Protein From Freemen Nutra That's Revolutionizing Cognitive Enhancement

    Memo-Q breaks the mold in cognitive enhancement. This silk protein-derived ingredient from Freemen Nutra has 10 human clinical trials showing memory and learning benefits across ALL ages -- from 7-year-olds to 90+ seniors. Four mechanisms, one powerful ingredient. 400-600mg daily.

    BDNF Stimulation: Building Cognitive Resilience

    Beyond neurotransmitter modulation, Memo-Q significantly increases Brain-Derived Neurotrophic Factor (BDNF) expression in hippocampal tissue.[4] This growth factor is crucial for neuroplasticity -- the brain's ability to form new connections and adapt to changing hormonal environments.

    BDNF activates multiple critical pathways for neuronal survival and growth, helping to convert short-term memories into long-term ones.[4] Research shows that amyloid beta suppresses BDNF expression, but Memo-Q counteracts that suppression, maintaining healthy BDNF levels even in the presence of neurotoxic challenges.

    For menopausal women, enhanced BDNF means better adaptation to estrogen decline, improved memory consolidation, and protection against age-related cognitive decline. The neuroplasticity benefits extend beyond memory: BDNF promotes the generation of new neurons and synapses while protecting existing ones from death. With both neurogenesis and neuroprotection from improved BDNF, Memo-Q creates an environment where the brain can maintain cognitive flexibility, adapt to new challenges, and preserve function despite aging or stress.

    The 400mg dose ensures robust BDNF stimulation based on the dose-response relationships observed in research, providing the foundation for sustained cognitive enhancement throughout the hormonal transition of menopause.

    Enhanced Cerebral Blood Flow

    Memo-Q addresses another critical component of brain fog: compromised blood flow to cognitive centers. Clinical research using brain imaging demonstrates significant increases in cerebral perfusion to brain regions critical for memory formation and retrieval.[5] Participants showed measurable increases in blood flow alongside cognitive improvements, with mean IQ scores increasing from 103 to 114 after three weeks of supplementation.

    Memo-Q Brand Logo and Main Benefits Overview

    This silk protein-derived nootropic claims the top spot for memory research, targeting four key areas of brain function you want to optimize.

    Enhanced cerebral circulation delivers more oxygen and glucose to active neurons while efficiently removing metabolic waste products. This improved vascular function directly counters the circulation changes that can accompany menopause, supporting sustained mental energy throughout the day.

    Neuroprotection and Antioxidant Defense

    Memo-Q provides neuroprotective benefits through multiple complementary mechanisms. Research demonstrates protection against a large array of neurotoxic challenges, ranging from toxicities to hazardous mineral complexes to surgically-induced insults.[6]

    When challenged with amyloid beta (the protein that forms toxic plaques associated with neurodegeneration), Memo-Q significantly reduced pro-inflammatory cytokines in brain hippocampal tissue.[4] Similarly, when neurons were challenged with scopolamine (which blocks acetylcholine receptors and induces memory impairment), Memo-Q treatment significantly reduced the same inflammatory markers.[3]

    This multi-target neuroprotection appears to work through several mechanisms simultaneously. Memo-Q maintains mitochondrial function under oxidative stress, preserves cellular energy production, and prevents the accumulation of reactive oxygen species that damage neuronal membranes and DNA.

    Memo-Q Manufacturing Process from Silk to Brain Supplement

    This diagram shows how silk fibroin gets enzymatically broken down into the bioactive peptides that power your cognitive enhancement.

    The Peptide Advantage

    What makes Memo-Q uniquely effective is its source: enzymatically hydrolyzed fibroin creates bioactive peptides that efficiently cross the blood-brain barrier and remain stable in the bloodstream. Unlike synthetic compounds or poorly absorbed plant extracts, these silk-derived peptides work through multiple pathways simultaneously: acetylcholine enhancement, BDNF stimulation, neuroprotection, and vascular support as mentioned above.

    Metabolic Synergy

    Research reveals an unexpected benefit: Memo-Q enhances glucose metabolism and insulin sensitivity.[7][8] This metabolic support not only provides neurons with the energy needed for demanding cognitive tasks but creates perfect synergy with our chocolate delivery system. Enhanced glucose uptake helps optimize the natural mood and energy benefits from cocoa while supporting sustained cognitive performance.

    At 100mg per chocolate square, you could max dose up to 6 squares, but 3-4 squares would be optimal in terms of price and performance.

    You can learn more in our article titled "Memo-Q: The Silk Protein From Freemen Nutra That's Revolutionizing Cognitive Enhancement".

  • effera™ Human Lactoferrin (200mg): Precision-Engineered Iron Intelligence

    The inclusion of 200mg effera™ addresses a critical yet overlooked aspect of menopausal cognitive health: iron dysregulation and inflammation. This isn't your typical lactoferrin supplement, either: effera™ represents a breakthrough in precision fermentation technology, creating the world's first commercially available human-identical lactoferrin.

    The Estrogen-Lactoferrin Connection

    Here's what most formulators miss: lactoferrin production is estrogen-mediated.[9] As estrogen declines during menopause, endogenous lactoferrin production plummets dramatically, creating a double deficit that contributes to both fatigue and cognitive dysfunction. This hormonal connection explains why so many menopausal women experience unexplained energy crashes and brain fog despite seemingly adequate nutrition.

    Memo-Q Clinical Research Summary with Study Count

    Ten human trials spanning ages 7 to 94 demonstrate Memo-Q's broad applicability across diverse populations.

    effera™ compensates for this estrogen-related decline while avoiding the immune complications that plague bovine lactoferrin supplementation. The human-identical structure ensures the body recognizes it as "self", preventing the inflammatory cascade that can occur with foreign proteins.

    Clinical Superiority: Human vs. Bovine

    The most powerful evidence for effera™'s advantages comes from head-to-head clinical studies. In a randomized, double-blind controlled trial, participants taking bovine lactoferrin developed antibodies against the protein, indicating their immune systems were actively trying to clear it as a foreign substance.[10]

    In stark contrast, participants taking effera™ showed zero antibody development at any dose level, demonstrating that the body accepts it as native human protein! This finding has profound implications: if the immune system is actively clearing bovine lactoferrin, it cannot remain in circulation long enough to provide optimal benefits.

    Additionally, effera™ digests identically to native human lactoferrin, breaking down into the same bioactive peptides that provide specific health benefits. Bovine lactoferrin digests differently, producing different peptide fragments that may not deliver the same therapeutic effects. This ingredient is the future, and it's here today.

    Advanced Iron Regulation

    As we learned in our podcast interviews with Helaina's team (Episodes #167 and #180), effera™ demonstrates sophisticated iron management through several key mechanisms:

    • Dual iron-binding sites that act like "biological magnets", grabbing iron with extraordinary affinity and responding to local tissue needs
    • "Intelligent" distribution that helps both iron-deficient and iron-overloaded individuals by modulating availability rather than simply adding more iron
    • Anemia of inflammation support - addresses the root cause when adequate iron exists but isn't being delivered where needed (affecting over 80% of pregnant women and increasingly recognized in perimenopausal women)
    • Enhanced iron transport from tissues into circulation where it's actually needed, explaining why women report improved energy even with "normal" iron studies
    Memo-Q Research Credentials Timeline

    Two decades of research backing Memo-Q sets it apart from typical nootropics that rely on just a few studies.

    This approach makes effera™ an alternative to traditional iron supplements, helping regulate iron levels rather than simply flooding the system with more iron.

    Bone Health Synergy

    Beyond cognitive benefits, effera™ provides targeted support for postmenopausal bone health. Research demonstrates significant improvements in bone turnover markers in postmenopausal women, with lactoferrin helping to preserve bone homeostasis.[11] This is especially relevant for the aging female demographic.

    Synergy with Memo-Q

    The combination of effera™ and Memo-Q creates powerful synergistic effects:

    • Complementary anti-inflammatory pathways - effera™'s "dampening of inflammation manyfold larger" than bovine lactoferrin perfectly complements Memo-Q's neuroprotective effects
    • Enhanced cellular energy - optimal iron delivery supports the increased glucose metabolism and mitochondrial function promoted by Memo-Q
    • BDNF amplification - both ingredients support neuroplasticity through different but complementary mechanisms
    • Vascular optimization - improved iron transport enhances the cerebral blood flow benefits demonstrated with Memo-Q
    Memo-Q Detailed Mechanisms of Action Explanation

    You're getting brain support through acetylcholine enhancement, BDNF stimulation, neuroprotection, and improved blood flow -- all from Memo-Q.

    The 200mg dose provides clinically meaningful support based on studies demonstrating improved hemoglobin levels and iron parameters in women across all life stages, from pregnancy through menopause.[12]

  • GeniusPure® Alpha-GPC 90% (235mg): The Next-Generation Choline Source

    With 235mg of GeniusPure® delivering 90% alpha-GPC, our formula provides a strategic dose optimized for both daily cognitive support and potential acute effects if you were to splurge. While most alpha-GPC products typically deliver 50% yield and suffer from stability issues, GeniusPure's advanced manufacturing achieves 90% purity with superior shelf-life characteristics.[13] This ensures consistent potency throughout our chocolate's shelf life while maximizing the active compound delivery in each square.

    Dual-Pathway Acetylcholine Enhancement

    Alpha-GPC provides unique advantages over basic choline supplements through its dual-mechanism approach. Upon absorption, GeniusPure® converts to both phosphorylcholine and free choline, creating multiple pathways for acetylcholine synthesis.[14] This dual substrate delivery ensures robust acetylcholine support that works synergistically with Memo-Q's acetylcholine preservation effects.

    Research demonstrates that alpha-GPC significantly increases acetylcholine release in the hippocampus, the brain region most critical for memory formation and retrieval.[15] Unlike simple choline salts that show limited brain penetration, alpha-GPC efficiently crosses the blood-brain barrier and directly supports neuronal membrane synthesis.

    Memo-Q Words Remembered Trial 1 vs Trial 5 Results

    Memo-Q supplementation helps you remember significantly more words on both initial learning and after repetition, with 400mg showing optimal first-trial performance.[16]

    Beyond Neurotransmitters: Comprehensive Brain Support

    The compound also contributes to membrane phospholipid synthesis, positively influencing neuron membranes and structural integrity.[14] During menopause, when estrogen's neuroprotective effects decline, maintaining healthy membrane composition becomes crucial for optimal brain function.

    Alpha-GPC also increases dopamine and serotonin levels in brain regions critical for motivation and mood regulation.[17] A study specifically examining motivation found that healthy volunteers taking 400mg alpha-GPC daily showed significant improvements in motivation levels, with effects most pronounced in the evening hours.[17]

    Why 235mg? Acute Support at Six Chocolates!

    In the opening sentence, we teased acute benefits if you were to splurge. Why 235mg in four chocolates? Besides the fact that it's more affordable and more easily fits into the form factor, it ensures that women taking six chocolate squares would reach the clinically-studied 350mg dose demonstrated to deliver acute cognitive benefits![13]

    In that randomized, double-blind, placebo-controlled crossover trial, participants taking a yield of 315mg alpha-GPC (equivalent to a 350mg GeniusPure® 90% dose) showed remarkable improvements in cognitive performance.[13]

    The results were striking: 108% improvement in Stroop test performance and 50% increase in processing speed compared to placebo, with effects appearing within 60 minutes of administration.[13] These cognitive tests specifically measure selective attention, cognitive flexibility, and information processing -- precisely the mental functions that decline during menopausal brain fog.

    Memo-Q Retrieval Efficiency Delayed Recognition Scores

    Memo-Q improves your ability to recall information after delays, though the effect plateaus around 400mg daily.[16]

    Perfect Synergy with Our Formula

    The 235mg GeniusPure® dose creates powerful synergy with our other ingredients:

    • Complements Memo-Q's acetylcholine preservation with fresh acetylcholine synthesis
    • Enhances B-vitamin methylation support through improved choline availability
    • Supports cellular energy production alongside magnesium and niacin

    This ensures that women experiencing menopausal brain fog receive both immediate cognitive enhancement and long-term neurological support, making our functional chocolate a complete solution for maintaining mental sharpness during this challenging transition.

    So it's a dose that's not too little, not too much, and enables maximum-strength dosing of both Memo-Q and GeniusPure together in six chocolates.

  • Xeya® Shatavari (50mg): The Queen of Ayurveda Meets Modern Science

    Shatavari (Asparagus racemosus), known as the "Queen of Ayurveda", has been treasured for centuries as a primary female reproductive tonic.[18] This adaptogenic herb traditionally supports hormonal balance throughout a woman's life stages (from menstruation through menopause), making it a perfect complement to our Memo-Q-centered cognitive formula.

    Breakthrough Clinical Evidence

    The scientific validation of shatavari has reached new heights with recent groundbreaking research. A newly published randomized, double-blind, placebo-controlled trial demonstrated remarkable efficacy of NXT-USA's standardized shatavari extract, Xeya® Shatavari, in perimenopausal women.[19]

    Memo-Q Memory Retention Statistical Significance Chart

    Both 400mg and 600mg doses of Memo-Q deliver statistically significant improvements in how well you retain learned information.[16]

    Over 120 days, women taking 50mg daily of this 15% shatavarin-standardized extract experienced a 51% reduction in Menopausal Rating Scale scores, with even greater benefits at 100mg (73% reduction). Hot flash severity decreased by 28% at the lower dose, while menstrual symptoms showed marked improvement across multiple domains.[19]

    Most impressive were the hormonal changes: FSH levels dropped 52%, LH decreased 30%, while anti-Müllerian hormone (AMH) (a key marker of ovarian reserve) increased by 125% at the 50mg dose. Ovarian follicle counts increased by 34%, suggesting genuine improvement in reproductive function rather than mere symptom masking.[19]

    Mechanisms of Hormonal Support

    Shatavarins, the key bioactive compounds in shatavari, are steroidal saponins with demonstrated affinity for estrogen receptors.[20] Molecular docking studies reveal that multiple shatavarin compounds interact with estrogen alpha, beta, and gamma receptors, as well as progesterone, FSH, and LH receptors,[20] meaning there are hormonal modulatory effects that could help stabilize the fluctuations contributing to brain fog and other menopausal symptoms.[21]

    The clinical study reveals shatavari's dual regulatory mechanism: it appears to normalize hypothalamic-pituitary-gonadal axis homeostasis through enhanced negative feedback while supporting ovarian folliculogenesis and steroidogenesis. This bidirectional adaptogenic activity explains why it can simultaneously reduce elevated gonadotropins while supporting ovarian function.[19]

    Research also shows shatavari may provide additional health benefits through improved muscle function. A study in postmenopausal women found eight weeks of shatavari supplementation combined with resistance training increased handgrip strength and enhanced muscle protein regulation.[22] This physical strength component may translate to better overall vitality during the cognitively demanding menopausal transition.

    Memo-Q Memory Quotient Dose Response Study Results

    Memo-Q delivers clear dose-dependent improvements in memory function, with the highest 600mg dose delivering nearly 25-point gains over placebo.[16]

    Xeya®: Next-Generation Shatavari from NXT-USA

    For our formula, we've selected Xeya® Modern Shatavari from NXT-USA at 50mg daily in four chocolates, which is a breakthrough in shatavari technology. Traditional shatavari extracts typically require 500-1000mg doses, but Xeya's advanced standardization to 15% shatavarins allows effective dosing at just one-tenth the typical amount.

    According to NXT-USA, Xeya® is "twice as effective at one-fifth the dose" compared to conventional shatavari extracts. This potency advantage makes it perfect for our chocolate format while ensuring clinically meaningful hormonal support. Most importantly, Xeya was used in the groundbreaking perimenopausal study mentioned above.[19]

    While another study on PCOS remains pending publication, the published perimenopausal research provides compelling evidence for Xeya's efficacy at this 50mg dose.[19]

    Beyond Hormones: Other Wellness Benefits (Skin Quality)

    The clinical trial revealed benefits extending beyond hormonal balance. Participants saw significant improvements in skin quality, with acne severity scores declining 46% and perceived skin quality increasing 99%.[19] Hair quality parameters showed equally impressive improvements: 100% reduction in hair fall, 121% improvement in texture, and 162% increase in volume.

    The inclusion of Xeya® alongside Memo-Q transforms our formula from purely cognitive support into a very well-rounded approach addressing both the neurological and hormonal aspects of menopausal brain fog, with some skin care benefits to boot. NXT-USA looks to have established Xeya® as the new benchmark for shatavari supplementation.

  • Strategic Mineral Support

    Memo-Q Learning Gradient Percentage Change Chart

    Memo-Q helps you learn material more efficiently at higher doses, though the improvements level off as you increase from 400mg to 600mg daily.[16]

    • Iron Bisglycinate (4mg, 50% DV)

      Beyond effera™'s sophisticated iron regulation lies a crucial but underappreciated truth: iron deficiency directly impairs cognitive function, even in otherwise healthy adults.

      The Iron-Cognition Connection: Hidden Mechanisms Behind Brain Fog

      Research demonstrates that iron-deficient women show significant deficits in attention, memory, and learning, and these are deficits that normalize following restoration of iron status.[23]

      Neurotransmitter Synthesis Disruption

      Iron serves as an essential cofactor for the rate-limiting enzymes in dopamine and serotonin synthesis.[24] When iron stores decline, neurotransmitter production falters. This explains why iron-deficient women report the exact symptoms we see in menopause: difficulty concentrating, mental fatigue, and mood changes.

      Research reveals iron deficiency decreases dopamine receptors in brain regions critical for attention and executive function.[23] The dopaminergic system strongly correlates with cognitive performance throughout the adult lifespan, making iron optimization crucial for maintaining mental acuity during menopause.

      Cellular Energy Metabolism

      Iron deficiency compromises fundamental cellular bioenergetics for mitochondrial ATP production. The brain regions most affected, the hippocampus and frontal cortex, are also those involved in memory formation and executive function.[24] The combination of some iron with effera™'s intelligent iron delivery ensures these energy-demanding cognitive centers receive adequate iron for optimal mitochondrial function, so that nothing holds Memo-Q's potential benefits back.

    • Zinc Picolinate (8mg, 73% DV)

      Memo-Q Complex Figure Test Before After Comparison

      Memo-Q enhances visuospatial memory tasks in a dose-dependent manner, with 600mg delivering the strongest gains in complex pattern recall.[16]

      Zinc picolinate at an 8mg yield of zinc provides meaningful support for cognitive and hormonal pathways critical during menopause. Research shows zinc picolinate demonstrates superior bioavailability compared to other zinc forms, with significant increases in hair, urine, and red blood cell zinc levels.[25]

      For menopausal women, zinc provides multifaceted benefits:[26]

      • Hormone regulation support: Zinc modulates estrogen receptor activity and supports healthy testosterone levels, helping balance the hormonal fluctuations that contribute to brain fog.
      • Antioxidant defense: As a cofactor for superoxide dismutase, zinc provides crucial protection against oxidative stress that increases during menopause. This antioxidant activity works synergistically with Memo-Q's neuroprotective effects.
      • Neurotransmitter synthesis: Zinc serves as a cofactor for enzymes involved in dopamine, serotonin, and GABA production -- neurotransmitters often imbalanced during menopause.
      • Immune system support: Declining estrogen compromises immune function, while zinc helps maintain robust immune response and reduces inflammatory markers that can contribute to brain fog.
      • Sleep quality enhancement: Research shows zinc supplementation improves sleep onset and quality, addressing another common menopause complaint that directly impacts cognitive function.
    • Magnesium Glycinate (Yielding 50mg, 12% DV)

      While space constraints limit us to 50mg elemental magnesium from glycinate, this amount still provides meaningful benefits. The glycinate form offers superior absorption and the added benefit of glycine for neurotransmitter support.[27]

      Memo-Q Four Mechanisms of Action Overview

      Unlike single-pathway nootropics, you're getting comprehensive brain support through Memo-Q's four distinct biological mechanisms.

      Even at this dose, magnesium glycinate contributes to:[28]

      • NMDA receptor modulation for cognitive function
      • Sleep quality support addressing a common menopause complaint
      • Stress response regulation through HPA axis modulation

      Note for formulators: If creating a powder or larger serving size, consider increasing to 100-200mg for more robust effects. We can only fit so much into a chocolate, as magnesium glycinate has only a 10% magnesium yield.

  • The B-Vitamin Trinity: Folate, B12, and Niacin

    • Folinic Acid (400mcg DFE, 100% DV)

      For our folate source, we've selected folinic acid over folic acid for superior bioavailability and immediate metabolic availability. Unlike folic acid, folinic acid bypasses the DHFR enzyme bottleneck that creates delays and potential accumulation, which is crucial for the 40% of women with MTHFR polymorphisms that compromise folate metabolism.[29]

      Direct Neurotransmitter Support

      Folinic acid directly supports the methylation pathways essential for neurotransmitter synthesis: dopamine, serotonin, and norepinephrine production all require adequate folate cofactors.[30] During menopause, declining estrogen disrupts these same pathways, making optimal folate status critical for maintaining mood stability and cognitive clarity. This active form ensures immediate availability for methylation reactions without metabolic conversion delays.

      Memo-Q Cognitive Performance Improvements by Category

      You'll see impressive double-digit improvements across memory, learning, and focus tests when you supplement with Memo-Q.

      Homocysteine Regulation and Brain Health

      The 400mcg dose provides support for homocysteine metabolism, working synergistically with methylcobalamin to prevent the elevation that commonly occurs during menopause. Elevated homocysteine directly impairs cognitive function and increases cardiovascular risk -- two primary concerns for women in this demographic. Research demonstrates folinic acid's superior efficacy in reducing homocysteine levels compared to folic acid, while avoiding the unmetabolized folic acid syndrome that can interfere with natural folate utilization.[30]

      This is the folate source more women need to know about.

    • Methylcobalamin (6mcg, 250% DV)

      Methylcobalamin at 6mcg provides B12 support in its most bioactive form, addressing multiple pathways that commonly decline during menopause. This active coenzyme form bypasses the cellular conversion steps required by cyanocobalamin, ensuring immediate metabolic availability.[31]

      B12 deficiency affects up to 40% of adults over 60, making supplementation crucial during menopause when absorption naturally declines.[32] The vitamin serves as an essential cofactor in maintaining healthy homocysteine levels and supporting cellular energy production.

      Most importantly, B12 plays a fundamental role in neurotransmitter synthesis and neuronal structural maintenance.[32] Clinical research in middle-aged and elderly adults with cognitive impairment showed that B12 supplementation significantly improved attention, calculation, and visuospatial function, which are the same cognitive domains affected by menopausal brain fog.[32] This form works synergistically with folinic acid to optimize methylation pathways essential for cognitive function, preventing the "folate trap" that can occur with inadequate B12 status.

    • Niacin as Nicotinic Acid (12mg, 75% DV)

      Memo-Q Available Supplement Delivery Formats

      You'll find Memo-Q in everything from traditional capsules to functional foods and ready-to-drink beverages.

      A strategic 12mg of nicotinic acid provides robust NAD+ support while staying comfortably below flushing thresholds. This dose delivers meaningful cognitive and metabolic benefits without the vasodilation effects that typically begin around 50mg.[33]

      NAD+ and Cellular Energy Production

      Niacin serves as the precursor to NAD+ (nicotinamide adenine dinucleotide), a critical coenzyme involved in over 400 enzymatic reactions throughout the body.[34] During menopause, declining cellular energy production contributes significantly to brain fog and mental fatigue.

      By supporting NAD+ synthesis, nicotinic acid directly enhances mitochondrial function in energy-demanding brain regions like the hippocampus and frontal cortex: areas crucial for memory formation and executive function.[34] Research demonstrates that optimal NAD+ levels help restore mitochondrial function and counteract cognitive decline associated with aging and hormonal changes.

      Cerebral Blood Flow Enhancement

      Nicotinic acid promotes vasodilation specifically in cerebral vessels, increasing blood flow to cognitive centers.[34] This enhanced cerebral circulation delivers more oxygen and glucose to active neurons while efficiently removing metabolic waste products, directly addressing the circulation changes that can accompany menopause and contribute to mental sluggishness.

      Studies show that niacin increases local cerebral blood flow.[34] This vascular support creates perfect synergy with Memo-Q's own cerebral blood flow benefits, amplifying the overall cognitive enhancement effect.

The Chocolate Matrix: More Than Just Taste

The dark chocolate base (70% cacao) isn't merely a delivery vehicle, it's an active component providing small amounts of:

Formulator's Corner #20: Menopause Brain Fog Formula - Memo-Q Meets Functional Chocolate

  • Flavonoids for additional cognitive and vascular benefits
  • Theobromine for gentle stimulation without jitters
  • Anandamide for mood support
  • Natural antioxidants complementing our formula's anti-inflammatory approach

Expected Outcomes: A Timeline of Cognitive Support

Week 1-2: Initial Response

  • Improved mental energy from B-vitamin and iron support
  • Better focus from Cognizin's rapid effects
  • Mood elevation from both chocolate and early Memo-Q activity

Week 4-6: Cognitive Momentum

  • Noticeable memory improvements as Memo-Q reaches optimal levels
  • Reduced brain fog episodes
  • Better mental clarity throughout the day
  • Improved sleep quality from magnesium

Week 8-12: Sustained Enhancement

  • Consistent cognitive performance
  • Reduced word-finding difficulties
  • Better multitasking ability
  • Overall sense of mental sharpness returning

3+ Months: Long-term Optimization

  • Sustained BDNF elevation supporting ongoing neuroplasticity
  • Optimized iron status without supplementation fatigue
  • Consistent cholinergic support maintaining memory function
  • Reduced inflammation markers supporting brain health

Market Opportunity: Meeting Women Where They Are

The menopause supplement market will continue to grow tremendously through the decade, and cognitive support is potentially the fastest-growing segment. However, most brands offer generic "women's formulas" that don't have a fraction of the potential of a formula like this.

Our Memo-Q-centered functional chocolate represents a genuine innovation:

  • First silk protein cognitive formula specifically for menopause
  • Clinically-relevant doses of research-backed ingredients
  • Indulgent format that encourages compliance
  • Comprehensive approach addressing multiple pathways simultaneously

Target Consumer Profile

Digexin

Digexin is the next major gut health ingredient. Developed by NXT and distributed by Freemen Nutra, this patented blend of ashwagandha and okra root extracts marks a significant advancement in addressing constipation and overall gut health.

  • Primary: Professional women 45-55 navigating peak career demands while managing menopause. These women have disposable income, prioritize cognitive performance, and seek science-backed solutions.
  • Secondary: Active women 50-65 focused on maintaining mental sharpness. They value quality of life, understand the importance of cognitive health, and appreciate the functional chocolate format.

Formulation Flexibility

Brands can adapt this formula based on positioning:

Premium Version

  • 400mg Memo-Q
  • All ingredients at suggested doses
  • Organic, fair-trade chocolate base
  • Individual wrapped squares for portion control

An even more advanced version could include Shoden®-R ashwagandha for mood and cortisol control in a form that requires a lower dose and doesn't alter taste as much as other forms of ashwagandha.

Value Version

  • 280mg Memo-Q (still clinically effective)
  • Slightly reduced choline and mineral doses
  • Standard dark chocolate base
  • Bar format for cost efficiency

For recommended use, we'd suggest users to eat 4 squares daily, preferably divided into 2 servings (morning and afternoon) for sustained cognitive support. Can be enjoyed with or without food.

Safety and Considerations

This formula is designed for daily, long-term use with an excellent safety profile:

Freemen Nutra Logo

  • All ingredients are GRAS or have extensive safety data
  • No hormone replacement therapy interactions
  • Monitor total iron intake if taking additional supplements

The Bottom Line: Cognitive Renaissance in Every Square

This Memo-Q-powered functional chocolate represents more than symptom management -- it's a comprehensive approach to maintaining cognitive vitality during menopause. By combining breakthrough silk protein technology with proven nutrients in an enjoyable format, we're offering women a solution that acknowledges both the science and the experience of this life transition.

The formula addresses the multifactorial nature of menopausal brain fog:

  • Neurotransmitter support through acetylcholine preservation and synthesis
  • Neuroplasticity enhancement via BDNF stimulation
  • Metabolic optimization through iron regulation and B-vitamins
  • Inflammation reduction from multiple complementary pathways
Digexin with Eric Withee of Freemen Nutra on the PricePlow Podcast

Explore the first dietary supplement ingredient that works on the gut-brain axis, Digexin, with Freemen Nutra's Eric Withee on the PricePlow Podcast Episode #147. The data is unlike anything we've ever seen!

For brands ready to move beyond generic women's supplements, this represents an opportunity to lead in the rapidly growing menopause wellness category. The science is solid, the ingredients are available, and the market is ready.

Call to Action: Women's Formulas Need a Tune-Up

The women navigating menopause deserve better than being told brain fog is "just part of aging". They deserve targeted, effective solutions that honor both their immediate needs and long-term cognitive health.

We challenge brands to bring a vision like this with Memo-Q and create something that combines indulgence with efficacy, science with satisfaction.

Stay updated on the latest developments in cognitive health ingredients by subscribing to PricePlow's Memo-Q and Freemen Nutra news alerts:

Subscribe to PricePlow's Newsletter and Alerts on These Topics

Topic Blog Posts YouTube Videos Instagram Posts
Freemen-Nutra
Memo-Q

All PricePlow Articles Mentioning Memo-Q

About the Author: PricePlow Staff

PricePlow Staff

PricePlow is a team of supplement industry veterans that include medical students, competitive strength athletes, and scientific researchers who all became involved with dieting and supplements out of personal need.

The team's collective experiences and research target athletic performance and body composition goals, relying on low-toxicity meat-based diets.

No Comments | Posted in , , , , | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , .

References

  1. Maki, Pauline M., et al. "Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations." Journal of Women's Health, vol. 28, no. 2, Feb. 2019, pp. 117–134, doi:10.1089/jwh.2018.27099.mensocrec. https://pubmed.ncbi.nlm.nih.gov/30182804/
  2. Lee, Sang Hyung, et al. "The Improvement of Learning and Memory Ability of Normal Persons by BF-7." Korean Journal of Physiology and Pharmacology, vol. 8, no. 6, Dec. 2004, pp. 307–312. https://snu.elsevierpure.com/en/publications/the-improvement-of-learning-and-memory-ability-of-normal-persons-
  3. "Mechanistic and Efficacy Study on Effects of Fibroin Enzymatic Hydrolysate (FEH) on Memory and Learning Impairments Induced by Scopolamine in Mice." Heraldopenaccess.us, 2021. https://www.heraldopenaccess.us/openaccess/mechanistic-and-efficacy-study-on-effects-of-fibroin-enzymatic-hydrolysate-feh-on-memory-and-learning-impairments-induced-by-scopolamine-in-mice
  4. "Beneficial and Mechanistic Effects of a Fibroin Enzymatic Hydrolysate on Memory Impairment Induced by Amyloid Beta in Mice." Heraldopenaccess.us, 2020. https://www.heraldopenaccess.us/openaccess/beneficial-and-mechanistic-effects-of-a-fibroin-enzymatic-hydrolysate-on-memory-impairment-induced-by-amyloid-beta-in-mice
  5. Lee, Sang Hyung, et al. "Association between Cerebral Blood Flow and Cognitive Improvement Effect by B. Mori Extracted Component." Journal of Sericultural and Entomological Science, vol. 46, no. 2, 2004. https://www.researchgate.net/publication/263648252_Association_between_Cerebral_Blood_Flow_and_Cognitive_Improvement_Effect_by_B_mori_Extracted_Component
  6. Chae, Hee-Sun, et al. "The Role of BF-7 on Neuroprotection and Enhancement of Cognitive Function." The Korean Journal of Physiology and Pharmacology, 2025, pp. 173–179. https://pesquisa.bvsalud.org/portal/resource/e/wpr-727927
  7. Kim, Eun-Do, et al. "Fibroin-Derived Peptides Stimulate Glucose Transport in Normal and Insulin-Resistant 3T3-L1 Adipocytes." Biological and Pharmaceutical Bulletin, vol. 32, no. 3, 1 Jan. 2009, pp. 427–433, doi:10.1248/bpb.32.427. https://www.jstage.jst.go.jp/article/bpb/32/3/32_3_427/_article
  8. Lee, Hyun-Sun, et al. "Silk Protein Hydrolysate Increases Glucose Uptake through Up-Regulation of GLUT 4 and Reduces the Expression of Leptin in 3T3-L1 Fibroblast." Nutrition Research, vol. 31, no. 12, 11 Nov. 2011, pp. 937–943, doi:10.1016/j.nutres.2011.09.009. https://pubmed.ncbi.nlm.nih.gov/22153520/
  9. Teng, C. T. "Lactoferrin Gene Expression Is Estrogen Responsive in Human and Rhesus Monkey Endometrium." Molecular Human Reproduction, vol. 8, no. 1, 1 Jan. 2002, pp. 58–67, doi:10.1093/molehr/8.1.58. https://pubmed.ncbi.nlm.nih.gov/11756570/
  10. Peterson, Ross D, et al. "A Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Immunological and Safety Parameters in Healthy Adults." International Journal of Toxicology, vol. 44, no. 1, 2025, pp. 12–28, doi:10.1177/10915818241293723. https://pmc.ncbi.nlm.nih.gov/articles/PMC11731406/
  11. Bharadwaj, S., et al. "Milk Ribonuclease-Enriched Lactoferrin Induces Positive Effects on Bone Turnover Markers in Postmenopausal Women." Osteoporosis International, vol. 20, no. 9, 27 Jan. 2009, pp. 1603–1611, doi:10.1007/s00198-009-0839-8. https://pubmed.ncbi.nlm.nih.gov/19172341/
  12. Paesano, Rosalba, et al. "Lactoferrin Efficacy versus Ferrous Sulfate in Curing Iron Deficiency and Iron Deficiency Anemia in Pregnant Women." BioMetals, vol. 23, no. 3, 21 Apr. 2010, pp. 411–417, doi:10.1007/s10534-010-9335-z. https://pubmed.ncbi.nlm.nih.gov/20407805/
  13. Kerksick, Chad M. "Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men." Nutrients, vol. 16, no. 23, 9 Dec. 2024, pp. 4240–4240, doi:10.3390/nu16234240. https://pmc.ncbi.nlm.nih.gov/articles/PMC11644786/
  14. Flannery, Brenna M, et al. Characterization of Deoxynivalenol-Induced Anorexia Using Mouse Bioassay. Vol. 49, no. 8, 1 Aug. 2011, pp. 1863–1869, doi:10.1016/j.fct.2011.05.004. https://www.sciencedirect.com/science/article/pii/S0278691511001906
  15. Cuozzo, Concetta, et al. "DNA Damage, Homology-Directed Repair, and DNA Methylation." PLoS Genetics, vol. 3, no. 7, 2007, p. e110, doi:10.1371/journal.pgen.0030110. https://pubmed.ncbi.nlm.nih.gov/17616978/
  16. Kang, Yong, et al. "Effect of a Fibroin Enzymatic Hydrolysate on Memory Improvement: A Placebo-Controlled, Double-Blind Study." Nutrients, vol. 10, no. 2, 17 Feb. 2018, p. 233, doi:10.3390/nu10020233. https://pmc.ncbi.nlm.nih.gov/articles/PMC5852809/
  17. Villa, Federica, et al. "SPADs and SiPMs Arrays for Long-Range High-Speed Light Detection and Ranging (LiDAR)." Sensors, vol. 21, no. 11, 1 June 2021, p. 3839, doi:10.3390/s21113839. https://pmc.ncbi.nlm.nih.gov/articles/PMC8199503/
  18. Alok, Shashi, et al. "Plant Profile, Phytochemistry and Pharmacology of Asparagus Racemosus (Shatavari): A Review." Asian Pacific Journal of Tropical Disease, vol. 3, no. 3, Apr. 2013, pp. 242–251, doi:10.1016/s2222-1808(13)60049-3. https://pmc.ncbi.nlm.nih.gov/articles/PMC4027291/
  19. Yadav, Poonam, et al. "Clinical Assessment of CL22209, a Standardized Proprietary Extract of Asparagus Racemosus, for Mitigating Vasomotor and Menstrual Symptoms in Perimenopausal Women: A Randomized, Double-Blind, Placebo-Controlled Study." Functional Foods in Health and Disease, vol. 15, no. 7, 23 July 2025, pp. 415–443, doi:10.31989/ffhd.v15i7.1684. https://www.ffhdj.com/index.php/ffhd/article/view/1684
  20. Arora, Neelima, and Amit Kumar Banerjee. "Molecular Docking Analysis of Shatavarins with Female Hormonal Receptors." Bioinformation, vol. 20, no. 7, 31 July 2024, pp. 775–780, doi:10.6026/973206300200775. https://pmc.ncbi.nlm.nih.gov/articles/PMC11414329/
  21. Gudise, Vani S, et al. "Efficacy and Safety of Shatavari Root Extract for the Management of Menopausal Symptoms: A Double-Blind, Multicenter, Randomized Controlled Trial." Cureus, vol. 16, no. 4, 8 Apr. 2024, doi:10.7759/cureus.57879. https://pmc.ncbi.nlm.nih.gov/articles/PMC11079574/
  22. O'Leary, Mary F., et al. "Shatavari Supplementation in Postmenopausal Women Improves Handgrip Strength and Increases Vastus Lateralis Myosin Regulatory Light Chain Phosphorylation but Does Not Alter Markers of Bone Turnover." Nutrients, vol. 13, no. 12, 27 Nov. 2021, p. 4282, doi:10.3390/nu13124282. https://pmc.ncbi.nlm.nih.gov/articles/PMC8708006/
  23. Murray-Kolb, Laura E, and John L Beard. "Iron Treatment Normalizes Cognitive Functioning in Young Women." The American Journal of Clinical Nutrition, vol. 85, no. 3, 1 Mar. 2007, pp. 778–787, doi:10.1093/ajcn/85.3.778. https://www.sciencedirect.com/science/article/pii/S0002916523279861
  24. Khedr, Eman, et al. "Iron States and Cognitive Abilities in Young Adults: Neuropsychological and Neurophysiological Assessment." European Archives of Psychiatry and Clinical Neuroscience, vol. 258, no. 8, 20 June 2008, pp. 489–496, doi:10.1007/s00406-008-0822-y. https://pubmed.ncbi.nlm.nih.gov/18574611/
  25. Barrie, S A, et al. "Comparative Absorption of Zinc Picolinate, Zinc Citrate and Zinc Gluconate in Humans." Agents and Actions, vol. 21, no. 1-2, 1987, pp. 223–8, doi:10.1007/bf01974946. https://pubmed.ncbi.nlm.nih.gov/3630857/
  26. Kiouri, Despoina P, et al. "Multifunctional Role of Zinc in Human Health: An Update." PubMed, vol. 22, 1 Jan. 2023, pp. 809–827, doi:10.17179/excli2023-6335. https://pmc.ncbi.nlm.nih.gov/articles/PMC10539547/
  27. Schuette, S A, et al. "Bioavailability of Magnesium Diglycinate vs Magnesium Oxide in Patients with Ileal Resection." JPEN. Journal of Parenteral and Enteral Nutrition, vol. 18, no. 5, 1994, pp. 430–5, doi:10.1177/0148607194018005430. https://pubmed.ncbi.nlm.nih.gov/7815675/
  28. Kawai, Nobuhiro, et al. "The Sleep-Promoting and Hypothermic Effects of Glycine Are Mediated by NMDA Receptors in the Suprachiasmatic Nucleus." Neuropsychopharmacology, vol. 40, no. 6, 1 May 2015, pp. 1405–1416, doi:10.1038/npp.2014.326. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397399/
  29. Scaglione, Francesco, and Giscardo Panzavolta. "Folate, Folic Acid and 5-Methyltetrahydrofolate Are Not the Same Thing." Xenobiotica; the Fate of Foreign Compounds in Biological Systems, vol. 44, no. 5, 2014, pp. 480–8, doi:10.3109/00498254.2013.845705. https://pubmed.ncbi.nlm.nih.gov/24494987/
  30. Menezo, Yves, et al. "Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles." Biomolecules, vol. 12, no. 2, 24 Jan. 2022, p. 197, doi:10.3390/biom12020197. https://pmc.ncbi.nlm.nih.gov/articles/PMC8961567/
  31. Paul, Cristiana, and David M Brady. "Comparative Bioavailability and Utilization of Particular Forms of B12 Supplements with Potential to Mitigate B12-Related Genetic Polymorphisms." Integrative Medicine: A Clinician's Journal, vol. 16, no. 1, Feb. 2017, p. 42. https://pmc.ncbi.nlm.nih.gov/articles/PMC5312744/
  32. Zhou, Li, et al. "Vitamin B12 Supplementation Improves Cognitive Function in Middle Aged and Elderly Patients with Cognitive Impairment." Nutricion Hospitalaria, vol. 40, no. 4, 13 June 2023, doi:10.20960/nh.04394. https://pubmed.ncbi.nlm.nih.gov/37334792/
  33. Carlson, L. A. "Nicotinic Acid: The Broad-Spectrum Lipid Drug. A 50th Anniversary Review." Journal of Internal Medicine, vol. 258, no. 2, 1 Aug. 2005, pp. 94–114, doi:10.1111/j.1365-2796.2005.01528.x. https://pubmed.ncbi.nlm.nih.gov/16018787/
  34. Gasperi, Valeria, et al. "Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications." International Journal of Molecular Sciences, vol. 20, no. 4, 23 Feb. 2019, doi:10.3390/ijms20040974. https://pmc.ncbi.nlm.nih.gov/articles/PMC6412771/

Comments and Discussion (Powered by the PricePlow Forum)